COVID-19 vaccine acceptance and hesitancy in patients with immunobullous diseases: a cross-sectional study of the International Pemphigus and Pemphigoid Foundation

Br J Dermatol. 2021 Nov 29. doi: 10.1111/bjd.20906. Online ahead of print.ABSTRACTPatients with autoimmune bullous diseases (AIBDs) have faced considerable challenges during the COVID-19 outbreak.1 SARS-CoV-2 vaccines became an important public health solution, but the pandemic raised awareness of vaccine hesitancy.2 We aimed to investigate the currently unknown general vaccination status among AIBD patients to better inform vaccine practices in this cohort of potentially life-threatening inflammatory disorders.PMID:34842282 | DOI:10.1111/bjd.20906

Source: The British Journal of Dermatology - November 29, 2021 Category: Dermatology Authors: M Kasperkiewicz R Strong K Mead M Yale D Zillikens D T Woodley A Recke Source Type: research